References
- Abedi D, Feizizadeh S, Akbari V, Jafarian-Dehkordi A. 2013. In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res. Pharm. Sci. 8: 260-268.
- Bryan RA, Guimaraes AJ, Hopcraft S, Jiang Z, Bonilla K, Morgenstern A, et al. 2012. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens. Mycopathologia. 173: 463-471. https://doi.org/10.1007/s11046-011-9476-9
- De Guzman ZM, Cervancia CR, Dimasuay KG, Tolentino MM, Abrera GB, Cobar ML, et al. 2011. Radiation inactivation of Paenibacillus larvae and sterilization of American Foul Brood (AFB) infected hives using Co-60 gamma rays. Appl. Radiat. Isot. 69: 1374-1379. https://doi.org/10.1016/j.apradiso.2011.05.032
- Huclier-Markai S, Alliot C, Varmenot N, Cutler CS, Barbet J. 2012. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics. Curr. Top. Med. Chem. 12: 2642-2654.
- Hueting R, Tavare R, Dilworth JR, Mullen GE. 2013. Copper-64 radiolabelling of the C2A domain of synaptotagmin I using a functionalised bis(thiosemicarbazone): A pre- and postlabelling comparison. J. Inorg. Biochem. 128: 108-111. https://doi.org/10.1016/j.jinorgbio.2013.07.017
- Jeon YH, Lee HW, Lee YL, Kim JE, Hwang MH, Jeong SY, et al. 2011. Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer. Cancer. Biother. Radiopharm. 26: 671-679. https://doi.org/10.1089/cbr.2011.1081
- Kang CS, Sun X, Jia F, Song HA, Chen Y, Lewis M, et al. 2012. Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy. Bioconjug. Chem. 23: 1775-1782. https://doi.org/10.1021/bc200696b
- Otani Y, Yamada T, Kato S, Shikama N, Funakoshi K, Kuroda I, et al. 2013. Source strength assay of iodine-125 seeds sealed within sterile packaging. J. Appl. Clin. Med. Phys. 14: 4082.
- Somily AM. 2010. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli. Saudi. Med. J. 31: 507-511.
- Towers S. 2013. Improving the control of systematic uncertainties in precision measurements of radionuclide half-life. Appl. Radiat. Isot. 77: 110-114. https://doi.org/10.1016/j.apradiso.2013.03.003
- Ujjani C, Cheson BD. 2013. The current status and future impact of targeted therapies in non-Hodgkin lymphoma. Expert. Rev. Hematol. 6: 191-202. https://doi.org/10.1586/ehm.13.6
-
Vera DR, Eigner S, Henke KE, Lebeda O, Melichar F, Beran M. 2012. Preparation and preclinical evaluation of
$^{177}Lu$ -nimotuzumab targeting epidermal growth factor receptor overexpressing tumors. Nucl. Med. Biol. 39: 3-13. https://doi.org/10.1016/j.nucmedbio.2011.07.001 -
Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW. 2013. Sensitization of tumor to
$^{212}Pb$ radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51. Int. J. Radiat. Oncol. Biol. Phys. 85: 1119-1126. https://doi.org/10.1016/j.ijrobp.2012.09.015